Theriva Biologics, Inc. Net Income (Loss) Available to Common Stockholders, Diluted
Theriva Biologics, Inc. (TOVX) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$5.25 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-04.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2019-11-04
- Theriva Biologics, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2019-09-30 was -$5.25M.
- Theriva Biologics, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2019-06-30 was -$3.71M.
- Theriva Biologics, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2019-03-31 was -$3.97M.
- Theriva Biologics, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2018-09-30 was -$3.74M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 9 month |
|---|---|---|---|---|---|
| 2019-09-30 | -$5.25M 10-Q · filed 2019-11-04 | -$8.96M derived: sum of 2 quarters · filed 2019-11-04 | -$12.93M 10-Q · filed 2019-11-04 | ||
| 2019-06-30 | -$3.71M 10-Q · filed 2019-08-08 | -$7.68M 10-Q · filed 2019-08-08 | |||
| 2019-03-31 | -$3.97M 10-Q · filed 2019-05-08 | ||||
| 2018-09-30 | -$3.74M 10-Q · filed 2019-11-04 | -$4.21M 10-Q · filed 2018-11-08 | -$8.00M derived: sum of 2 quarters · filed 2019-11-04 | -$10.38M 10-Q · filed 2019-11-04 | |
| 2018-06-30 | -$4.26M 10-Q · filed 2019-08-08 | -$4.21M 10-Q · filed 2018-08-08 | -$6.63M 10-Q · filed 2019-08-08 | -$6.54M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | -$2.38M 10-Q · filed 2019-05-08 | -$2.32M 10-Q · filed 2018-05-08 | |||
| 2017-09-30 | -$17.82M 10-Q · filed 2018-11-08 | -$22.08M derived: sum of 2 quarters · filed 2018-11-08 | -$24.93M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | -$4.25M 10-Q · filed 2018-08-08 | -$7.10M 10-Q · filed 2018-08-08 | |||
| 2017-03-31 | -$2.85M 10-Q · filed 2018-05-08 | ||||
| 2016-09-30 | -$8.35M 10-Q · filed 2017-11-01 | -$17.63M derived: sum of 2 quarters · filed 2017-11-01 | -$24.88M 10-Q · filed 2017-11-01 | ||
| 2016-06-30 | -$9.28M 10-Q · filed 2017-08-03 | -$19.86M 10-Q · filed 2017-08-03 | |||
| 2016-03-31 | -$24.88M 10-Q · filed 2017-05-04 | ||||
| 2015-09-30 | -$10.91M 10-Q · filed 2016-11-01 | -$24.54M derived: sum of 2 quarters · filed 2016-11-01 | -$32.76M 10-Q · filed 2016-11-01 | ||
| 2015-06-30 | -$13.62M 10-Q · filed 2016-08-03 | -$25.98M 10-Q · filed 2016-08-03 | |||
| 2014-09-30 | -$4.91M 10-Q · filed 2015-11-05 | -$13.30M 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |